Navigation Links
AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 12, 2007 - AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel, targeted cancer medicines, announced today that it will present a total of 12 oral and poster presentations at the American Association for Cancer Research (AACR) Annual Meeting on April 14-18, 2007, in Los Angeles, California.

"We are very excited to share with the cancer community the pioneering oncology research platform AVEO has developed, which we believe may significantly enhance the probability of success and the efficacy of the next generation of targeted cancer therapies," said Tuan Ha-Ngoc, president and CEO of AVEO Pharmaceuticals. "AVEO is focusing on translating this groundbreaking science into new drugs that may have a significant impact on cancer patient care and more importantly, patient response and outcomes."

These presentations focus on several applications of AVEO's breakthrough Human Response Prediction(TM) Platform of in vivo inducible mouse models.

The abstracts selected for oral presentations at the AACR Annual Meeting are listed below:

-- Saturday, April 14, 2007 at 9:00 a.m. to 9:20 a.m. "Response prediction in engineered models: Using natural variation in preclinical tumor populations to assess the genetic context of drug response" - Educational Session: Validating Therapeutic Targets: In Vivo Models and Clinical Responses - Concourse E

-- Saturday, April 14, 2007 at 2:00 p.m. to 2:20 p.m. "Human-in-mouse tumors: Creating de novo human breast cancer in mice through ex vivo genetic manipulation of normal breast tissue" - Methods Workshop: Recent Advances in Mouse Models of Cancer - Concourse E

-- Wednesday, April 18, 2007 at 10:40 a.m. to 10:55 a.m. "Comprehensive in vivo genetic screens for tumor maintenance pathways in solid tumor models by retroviral mutagenesis" - Mini-symposium: Integrated Ge
'"/>




Page: 1 2 3

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:7/29/2014)... ROCKY HILL, Conn. , July 29, 2014 ... 28, 2014, Mike Swinford will be the company,s ... after a highly successful 22-year career at GE where he ... $200 million in annual revenue to over $5 billion. His ... Healthcare Global Services. "I am thrilled to ...
(Date:7/29/2014)... 29, 2014 McGraw-Hill Education Professional, a leading ... technical, and medical communities, has announced the launch of ... application of the world-renowned medical education platform. ... App , available for download onto all iOS and ... to gain access to valuable AccessMedicine diagnostic ...
(Date:7/29/2014)... 2014  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... second quarter 2014 financial results after the Nasdaq market ... host a live conference call and webcast to discuss ... morning, August 7, 2014 at 8:00 a.m. Eastern Time ... the live conference call by dialing 866-952-1907 (US) or ...
Breaking Medicine Technology:Numotion Names Mike Swinford CEO 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2
(Date:7/29/2014)... 29, 2014 The One Minute Herpes Cure ... Freeman, an herbal medicine specialist. Alison Freeman wanted to show ... , People interested in finding out more about this ... download it, as it is currently available in online format. ... natural remedies and herbal medicine tips that can help them ...
(Date:7/29/2014)... July 29, 2014 The Natural Multiple ... the inside story to Gary M. Levin’s cure program. ... cure method for this serious disorder. Levin says that ... conditions that can be found in patients. , ... surgeon. For many years, Levin has worked with patients ...
(Date:7/29/2014)... DailyGossip.org reveals in its Stop Sciatica in 8 ... of naturally overcoming sciatica, in less than 7 days. ... sufferers that the cure is simple to achieve, when ... method is described as very fast, as it promises ... minutes per day treatment plan. , Read more ...
(Date:7/29/2014)... Parker Waichman LLP, a national law ... by defective drugs and medical devices, reports that a ... Canada who allege that they were never warned about ... low testosterone injection Delatestryl (Court File No. 3704CP/14). The ... Ontario Superior Court of Justice. , “Testosterone lawsuits have ...
(Date:7/29/2014)... Denver, Colorado (PRWEB) July 29, 2014 Daily ... is a powerful and holistic system that will teach users ... been tried by thousands of people, from all over the ... of the symptoms of this disorder in as quickly as ... will be gone faster than imagined. , The Fibroids ...
Breaking Medicine News(10 mins):Health News:One Minute to Herpes Cure Review Reveals Simplest Herpes Treatment 2Health News:Natural Multiple Sclerosis Treatment Review Reveals the Inside Story to Gary M. Levin’s Cure Program 2Health News:Stop Sciatica in 8 Minutes Review Reveals the Way to Cure Sciatica Easily 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 3Health News:Amanda Leto’s Fibroids Miracle Review Reveals Clinically Proven Uterine Fibroids Cure System 2
... New guidelines, released by the Centers for Disease ... Control Practices Advisory Committee (HICPAC) outline steps to ... which are among the most deadly and costly ... for the Prevention of Intravascular Catheter-Related Infections" will ...
... information about vaccines from their children,s doctors, but some ... family members and even celebrities as sources of vaccine ... survey conducted by University of Michigan researchers to determine ... regards to vaccines, as well as to determine what ...
... News) -- Exercise is a good way for people with ... expert. "People who have arthritis are often scared to ... condition will only get worse if people don,t get moving," ... Fitness in Maywood, Ill., said in a news release. ...
... of applications from treating cancer to powering safer nuclear ... This milestone was confirmed yesterday, 31 March 2011, at ... in Cheshire. Scientists from across the world are celebrating ... which is set to impact fundamental science and change ...
... able to quickly distinguish individuals with active tuberculosis (TB) ... If the preliminary results of the study will be ... system could allow more effective strategies to control the ... was performed by a group of scientists from the ...
... health care publication reveals a multitude of barriers that keep ... breast cancer but offers tools to help countries improve ... Delivery in Low- and Middle-Resource Countries," published as a supplement ... compiles three consensus statements and 11 research papers that were ...
Cached Medicine News:Health News:CDC issues updated bloodstream infection prevention guidelines 2Health News:CDC issues updated bloodstream infection prevention guidelines 3Health News:U-M experts: Parents trust doctors most when it comes to information about vaccine safety 2Health News:Exercise Is Key for People With Arthritis: Expert 2Health News:EMMA milestone beams its way to a world first 2Health News:EMMA milestone beams its way to a world first 3Health News:A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease 2Health News:A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease 3Health News:Breast health global initiative offers unprecedented tools for developing nations 2Health News:Breast health global initiative offers unprecedented tools for developing nations 3
... The product is intended for ... spine following anterior fusion. The device ... addition, load sharing is enhanced through ... thickness. Anterior cervical single level interbody ...
... the newest addition to the ... plates. Ant-Cer addresses the unique ... the cervical spine. It enables ... to fit patients' unique needs. ...
... plate system is a family of plates ... provides for consistent, reliable fixation of plate ... or backout. This innovative design eliminates the ... implant your screws and the swivel ring ...
Investigational use spacer with Cantilever Transforminal Lumbar Interbody Fusion and instrumentation. For Investigational use only. 7 mm height....
Medicine Products: